Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chromatinization modulates topoisomerase II processivity. | Nat Commun | 2023 | 37891161 | PubTator, text mining | PubMed |
| Chromatinization Modulates Topoisomerase II Processivity. | bioRxiv | 2023 | 37873421 | PubTator, text mining | PubMed |
| In Silico Study of a Small Bioactive Molecule Targeting Topoisomerase II and P53-MDM2 Complex in Triple-Negative Breast Cancer. | ACS Omega | 2023 | 37867720 | PubTator, text mining | PubMed |
| Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity. | Front Immunol | 2023 | 37849756 | PubTator, text mining | PubMed |
| Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients. | Neoplasia | 2023 | 37839160 | PubTator, text mining | PubMed |
| To Break or Not to Break: The Role of TOP2B in Transcription. | Int J Mol Sci | 2023 | 37834253 | PubTator, text mining | PubMed |
| Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles. | Microbiol Spectr | 2023 | 37815349 | PubTator, text mining | PubMed |
| Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome. | Blood Adv | 2023 | 37792884 | PubTator, text mining | PubMed |
| A Route for Investigating Psoriasis: From the Perspective of the Pathological Mechanisms and Therapeutic Strategies of Cancer. | Int J Mol Sci | 2023 | 37762693 | PubTator, text mining | PubMed |
| Cardiotoxicity of anti-cancer drugs: cellular mechanisms and clinical implications. | Front Cardiovasc Med | 2023 | 37745115 | PubTator, text mining | PubMed |
| Transcriptional linkage analysis with in vivo AAV-Perturb-seq. | Nature | 2023 | 37730998 | PubTator, text mining | PubMed |
| Analysis of the mechanism of action of Euphorbia fischeriana Steud on cirrhosis based on network pharmacology. | Medicine (Baltimore) | 2023 | 37713886 | PubTator, text mining | PubMed |
| Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the future. | Front Cardiovasc Med | 2023 | 37711551 | PubTator, text mining | PubMed |
| Synthesis and cytotoxicity evaluation of novel 1,8-acridinedione derivatives bearing phthalimide moiety as potential antitumor agents. | Sci Rep | 2023 | 37699954 | PubTator, text mining | PubMed |
| Chemical-induced phase transition and global conformational reorganization of chromatin. | Nat Commun | 2023 | 37689690 | PubTator, text mining | PubMed |
| Poly(ADP-ribose) Polyremase-1 (PARP-1) Inhibition: A Promising Therapeutic Strategy for ETS-Expressing Tumours. | Int J Mol Sci | 2023 | 37686260 | PubTator, text mining | PubMed |
| New Views of the DNA Repair Protein Ataxia-Telangiectasia Mutated in Central Neurons: Contribution in Synaptic Dysfunctions of Neurodevelopmental and Neurodegenerative Diseases. | Cells | 2023 | 37681912 | PubTator, text mining | PubMed |
| Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment. | Front Pharmacol | 2023 | 37680708 | PubTator, text mining | PubMed |
| Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions. | Oncogenesis | 2023 | 37666817 | PubTator, text mining | PubMed |
| In Vitro Evaluation of Ferutinin Rich-Ferula communis L., ssp. glauca, Root Extract on Doxorubicin-Induced Cardiotoxicity: Antioxidant Properties and Cell Cycle Modulation. | Int J Mol Sci | 2023 | 37628916 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=10